Ipca Laboratories Limited (IPCALAB.NS) NSE

1,512.20

+4.5(+0.30%)

Updated at June 03 10:13AM

Currency In INR

Valuation

Market Cap406.17B
Enterprise Value408.61B
P/E Ratio33.52
PEG Ratio0.61
Price/Sales Ratio3.97
Price/Book Ratio4.74
Enterprise/Revenue3.99
Enterprise/EBITDA19.7

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.12
Operating Margin0.24

Management Effectiveness

Return On Assets0.09
Return On Equity0.15

Income Statement

Revenue96.46B
Revenue/Share380.28
Gross Profit61.83B
EBITDA19.54B
Net Income11.41B
Diluted EPS44.98

Balance Sheet

Total Cash11.98B
Total Cash/Share47.23
Total Debt8.09B
Total Debt/Equity0.1
Current Ratio2.76
Book Value Per Share375.46

Price History

52-Week Change6.49
52-Week High1,678.3
52-Week Low1,251.6
Moving Average 50 Days1,534.09
Moving Average 200 Days1,443.64

Statistics

Average Volume270,499
Shares Outstanding253.7M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate4
Trailing Annual Dividend Yield0.27
Payout Ratio0.05
Last Split Factor2:1
Last Split DateJanuary 10, 2022